Page last updated: 2024-08-23

etoposide and Cystadenocarcinoma, Serous

etoposide has been researched along with Cystadenocarcinoma, Serous in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (16.67)	18.2507
2000's	3 (25.00)	29.6817
2010's	6 (50.00)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Cai, S; Li, H; Sun, L; Wu, L; Yang, M; Zhang, X; Zhang, Y	1
Adbul-Karim, F; Link, N; Michener, CM; Radeva, M; Rose, PG	1
Khunnarong, J; Manusirivithaya, S; Pataradool, K; Pitakkarnkul, S; Prutthiphongsit, W; Srijaipracharoen, S; Tangjitgamol, S; Thavaramara, T	1
Curtin, J; Downey, A; Edwards, S; Kwa, M; Muggia, F; Reich, E; Wallach, R	1
Hoskins, P; Kumar, A; Le, N; Santos, J	1
Chang, QY; Li, M; Li, XG; Li, YF; Liu, J; Song, PP; Tian, HM; Wang, XB; Wu, LY; Zhang, W; Zhao, D	1
Blagden, S; Gabra, H; Graham, J; Sharma, R	1
Higashide, K; Kikkawa, F; Maeda, O; Misawa, T; Obata, NH; Suganuma, N; Tomoda, Y	1
Cheng, X; Itamochi, H; Kanamori, Y; Kigawa, J; Minagawa, Y; Oishi, T; Okada, M; Terakawa, N	1
Malik, IA	1
Gochi, A; Isozaki, H; Matsuno, T; Naomoto, Y; Shigemitsu, K; Tanaka, N	1
Mahmoudi, M; Meyer, T; Nelstrop, AE; Rustin, GJ	1

Trials

2 trial(s) available for etoposide and Cystadenocarcinoma, Serous

Article	Year
Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate	2013
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer. BMC cancer, 2011, Jul-11, Volume: 11 Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cisplatin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Tamoxifen; Thrombocytopenia; Treatment Outcome	2011

Article

Year

Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand.

Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:4

Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate

2013

Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.

BMC cancer, 2011, Jul-11, Volume: 11

Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cisplatin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Tamoxifen; Thrombocytopenia; Treatment Outcome

2011

Other Studies

10 other study(ies) available for etoposide and Cystadenocarcinoma, Serous

Article	Year
Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report. Medicine, 2020, Volume: 99, Issue:20 Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Indoles; Middle Aged; Ovarian Neoplasms; Quinolines	2020
Efficacy of Pegylated Liposomal Doxorubicin in Low-Grade Serous Ovarian Carcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Serous; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Polyethylene Glycols; Retrospective Studies	2017
Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin. Annals of surgical oncology, 2014, Volume: 21, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cystadenocarcinoma, Serous; Etoposide; Female; Floxuridine; Follow-Up Studies; Heterozygote; Humans; Injections, Intraperitoneal; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Survival Rate; Topotecan	2014
Chemotherapy is of Value in Second Line and Beyond, Relapsed High-grade, Serous Epithelial Ovarian Cancer: An Analysis of Outcomes Obtained With Oral Etoposide. American journal of clinical oncology, 2018, Volume: 41, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Serous; Etoposide; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies; Salvage Therapy; Survival Rate	2018
[Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:11 Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Luminescent Measurements; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Topotecan	2010
Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells. Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:1 Topics: Camptothecin; Carboplatin; Cisplatin; Cystadenocarcinoma, Serous; Drug Resistance; Drug Resistance, Multiple; Etoposide; Female; Glutathione; Glutathione Transferase; Humans; Ovarian Neoplasms; Tumor Cells, Cultured	1995
Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer. Cancer, 1998, Feb-15, Volume: 82, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Cisplatin; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome	1998
Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer. Japanese journal of clinical oncology, 2001, Volume: 31, Issue:2 Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Serous; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Prospective Studies; Topotecan	2001
Advanced gastric cancer with multiple lymph node metastasis successfully treated with etoposide, adriamycin and cisplatin. Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Serous; Doxorubicin; Etoposide; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Stomach Neoplasms	2001
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:12 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cystadenocarcinoma, Serous; Etoposide; Female; Hematologic Diseases; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Survival Rate; Treatment Outcome	2001